NASDAQ:EXPOExponent Stock Price, Forecast & News

$76.70

-0.86 (-1.11 %)

(As of 06/4/2020 04:00 PM ET)

Add

Compare

Today's Range

$75.86

Now: $76.71▼

$77.37

50-Day Range

$62.72

MA: $69.39▼

$77.56

52-Week Range

$56.72

Now: $76.71▼

$82.82

Volume277,418 shs

Average Volume292,955 shs

Market Capitalization$3.95 billion

P/E Ratio47.94

Dividend Yield0.98%

Beta0.25

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
Exponent has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $86.33, Exponent has a potential upside of 12.6% from its current price of $76.71.
Amount of Analyst Coverage
Exponent has only been the subject of 1 research reports in the past 90 days.

2.4 Community Rank

Outperform Votes
Exponent has received 288 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Exponent has received 300 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Exponent has received 51.02% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Exponent and other stocks. Vote “Outperform” if you believe EXPO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EXPO will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Leadership
Exponent is a leading dividend payer. It pays a dividend yield of 0.98%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Exponent has been increasing its dividend for 5 years.
Dividend Coverage
The dividend payout ratio of Exponent is 49.67 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Exponent will have a dividend payout ratio of 46.06 % next year. This indicates that Exponent will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Exponent insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $841,938.00 in company stock.
Percentage Held by Insiders
Only 2.20% of the stock of Exponent is held by insiders.
Percentage Held by Institutions
88.84% of the stock of Exponent is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Exponent are expected to grow by 24.06% in the coming year, from $1.33 to $1.65 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Exponent is 47.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.21.
Price to Earnings Ratio vs. Sector
The P/E ratio of Exponent is 47.94, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 21.69.
Price to Book Value per Share Ratio
Exponent has a P/B Ratio of 11.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.22 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Management consulting services

Sub-IndustryResearch & Consulting Services

SectorBusiness Services

Current SymbolNASDAQ:EXPO

Previous Symbol

CUSIP30214U10

CIK851520

Webwww.exponent.com

Phone650-326-9400

Debt

Debt-to-Equity Ratio0.05

Current Ratio3.81

Quick Ratio3.81

Price-To-Earnings

Trailing P/E Ratio47.94

Forward P/E Ratio57.67

P/E GrowthN/A

Sales & Book Value

Annual Sales$417.20 million

Price / Sales9.48

Cash Flow$1.75 per share

Price / Cash Flow43.89

Book Value$6.76 per share

Price / Book11.35

Profitability

EPS (Most Recent Fiscal Year)$1.53

Net Income$82.46 million

Net Margins20.28%

Return on Equity25.03%

Return on Assets16.29%

Miscellaneous

Employees1,201

Outstanding Shares51,546,000

Market Cap$3.95 billion

Next Earnings Date7/16/2020 (Estimated)

OptionableOptionable

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Exponent (NASDAQ:EXPO) Frequently Asked Questions

How has Exponent's stock been impacted by COVID-19 (Coronavirus)?

Exponent's stock was trading at $75.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EXPO stock has increased by 0.9% and is now trading at $76.7050. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Exponent?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Exponent.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, July 16th 2020. View our earnings forecast for Exponent.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) issued its earnings results on Thursday, April, 30th. The business services provider reported $0.49 EPS for the quarter, beating the Zacks' consensus estimate of $0.42 by $0.07. The business services provider earned $99.70 million during the quarter, compared to analyst estimates of $101.21 million. Exponent had a net margin of 20.28% and a return on equity of 25.03%. Exponent's quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the business posted $0.42 earnings per share. View Exponent's earnings history.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Thursday, April 30th. Investors of record on Friday, June 12th will be paid a dividend of $0.19 per share on Friday, June 26th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date of this dividend is Thursday, June 11th. View Exponent's dividend history.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were distributed to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

5 equities research analysts have issued 1 year price objectives for Exponent's stock. Their forecasts range from $81.00 to $94.00. On average, they anticipate Exponent's stock price to reach $86.33 in the next twelve months. This suggests a possible upside of 12.6% from the stock's current price. View analysts' price targets for Exponent.

Has Exponent been receiving favorable news coverage?

News articles about EXPO stock have been trending negative recently, InfoTrie reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Exponent earned a news impact score of -2.6 on InfoTrie's scale. They also assigned news coverage about the business services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutExponent.

Are investors shorting Exponent?

Exponent saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,150,000 shares, an increase of 27.6% from the April 15th total of 901,400 shares. Based on an average daily trading volume, of 307,300 shares, the days-to-cover ratio is presently 3.7 days. Currently, 2.3% of the shares of the stock are short sold. View Exponent's Current Options Chain.

Who are some of Exponent's key competitors?

Some companies that are related to Exponent include Verisk Analytics (VRSK), Equifax (EFX), Nielsen (NLSN), FTI Consulting (FCN), CBIZ (CBZ), ICF International (ICFI), Huron Consulting Group (HURN), Resources Connection (RECN), CRA International (CRAI), VSE (VSEC), Franklin Covey (FC), Mistras Group (MG), Acacia Research (ACTG) and Odyssey Marine Exploration (OMEX). View all competitors.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Energy Transfer LP Unit (ET), Pfizer (PFE), Abbott Laboratories (ABT), Ford Motor (F), AT&T (T), Adobe (ADBE), Intel (INTC), Micron Technology (MU) and UnitedHealth Group (UNH).

Who are Exponent's key executives?

Exponent's management team includes the following people:

Dr. Paul R. Johnston, Exec. Chairman (Age 65)
Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 50)
Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 53)
Dr. Harri K. Kytomaa, Group VP & Principal Engineer (Age 60)
Dr. Steven J. Murray, Group VP & Principal Engineer (Age 44)

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.81%), Conestoga Capital Advisors LLC (3.29%), State Street Corp (3.15%), Riverbridge Partners LLC (1.77%), GW&K Investment Management LLC (1.75%) and Geode Capital Management LLC (1.68%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr and Richard Reiss. View institutional ownership trends for Exponent.

Which institutional investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, BlackRock Inc., Morgan Stanley, Morgan Stanley, Atlanta Capital Management Co. L L C, TimesSquare Capital Management LLC, Sandler Capital Management, and Wellington Management Group LLP. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Harri Kytomaa, John Pye, Paul R Johnston, and Richard L Schlenker Jr. View insider buying and selling activity for Exponent.

Which institutional investors are buying Exponent stock?

EXPO stock was purchased by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Redwood Investments LLC, The Manufacturers Life Insurance Company , State Street Corp, FDx Advisors Inc., FDx Advisors Inc., Bessemer Group Inc., and AXA. View insider buying and selling activity for Exponent.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $76.71.

How big of a company is Exponent?

Exponent has a market capitalization of $3.95 billion and generates $417.20 million in revenue each year. The business services provider earns $82.46 million in net income (profit) each year or $1.53 on an earnings per share basis. Exponent employs 1,201 workers across the globe.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff